IV hydration therapy involves administering fluids directly into a patient's vein to address dehydration issues. It is used to provide fluid and electrolytes to patients suffering from dehydration due to severe diarrhea, vomiting, flu, hangovers or during intense workouts. IV hydration therapy helps in faster rehydration compared to oral rehydration. With busy lifestyles and rising health consciousness, the demand for convenient rehydration methods like IV therapy is growing significantly.
The Global Europe IV Hydration Therapy Market is estimated to be valued at US$ 301.46 Mn in 2024 and is expected to exhibit a CAGR of 5.9% over the forecast period 2024 to 2030. IV hydration therapy offers immediate relief from dehydration, replenishes electrolytes and helps people feel better faster. This therapy is also increasingly being used preventively by fitness enthusiasts and young professionals to avoid dehydration. The growing awareness about the benefits of IV hydration therapy and convenience of use especially during travel or outdoor activities is fueling the growth of Europe IV hydration therapy market.
Key Takeaways
Key players operating in the Europe IV Hydration Therapy Market size are Thermo Fisher Scientific Inc, Bio-rad Laboratories, Lonza Group, Merck Millipore, Cell Signalling Technology Inc., F.Hoffmann La Roche Ltd., Novartis AG, Takeda Pharmaceutical Company, Agilent Technologies, Danaher Corporation, BioLegend Inc., Illumina, Phoenix Pharmaceuticals, Abcam plc. These players are focusing on new product launches, geographical expansions and mergers & acquisitions to gain market share in this high potential market.
The rising health consciousness coupled with busy lifestyle has created opportunities for on-demand IV hydration services. Several start-ups are offering mobile IV hydration vans and services in Europe for consumers to avail hydration therapy conveniently without visiting hospitals or clinics. The growth of telemedicine and internet-based services is further fueling the availability of these on-demand services across Europe.
The key players are expanding their presence globally to tap the large untapped opportunities. Europe serves as an important base to enter other high potential markets. Regions like Middle East, Asia Pacific and Latin America are witnessing significant economic growth and rising disposable income which is propelling the demand for convenient wellness services like IV hydration therapy. This is encouraging European players to expand overseas through collaborations with local players.
Market Drivers:
- Rising health consciousness and busy lifestyles: People have become more prone to dehydration owing to fast-paced lifestyle and lack of focus on hydration. The convenience of IV therapy is a major attraction.
- Growing incidences of gastrointestinal illnesses: Frequent business travels, pollution and changing food habits have increased cases of diarrhea, vomiting and other gastric issues for which IV therapy is effective in quick rehydration.
Market Restraints:
- High cost of therapy: IV hydration therapy is costly compared to oral rehydration. This restraints its uptake especially for preventive use.
- Limited medical reimbursements: Most medical insurance plans don't cover IV therapy expenses straining individuals opting for it repeatedly for preventive reasons. This acts as a price barrier.
Segment Analysis
The Europe IV Hydration Therapy market has three dominating sub segments- peripherally inserted central catheters (PICC), midlines and central venous catheters (CVC). Among these, peripherally inserted central catheters (PICC) sub segment dominates the market with over 30% share due to its advantages like long term usage in mild to moderate dehydrations. PICC lines provides easy and safe administration of IV fluids for extended period without causing too much discomfort to the patient. With growing preference for less invasive techniques, PICC line usage has grown substantially.
Global Analysis
The Western Europe region dominates the IV Hydration Therapy market in Europe. Countries like Germany, France and United Kingdom collectively account for around 60% market share due to established healthcare facilities and rising geriatric population with dehydration related health issues. These countries have advanced healthcare infrastructure and trained medical experts for safe administration of IV fluids. It is expected that Eastern Europe region will witness fastest growth during the forecast period with countries like Russia experiencing highest CAGR of around 8%. Healthcare sector development and growing medical tourism are factors driving the market in Eastern Europe region.
Explore Our More Blogs Here: https://www.ukwebwire.com/europe-iv-hydration-therapy-market-set-for-rapid-growth-driven-by-growing-patient-preferences/
